Form 4 Tracker
Traws Pharma, Inc.
TRAW

11 insider filings · Latest: Apr 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 16, 2026Apr 29 1:41 AMORBIMED ADVISORS LLC10% Owner
Purchase
597,729$1.67$998.2K1,203,250(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 16, 2026Apr 29 1:41 AMORBIMED ADVISORS LLC10% Owner
Purchase
2,988,645$1.671,793,187(I)

View →

Mar 8, 2026Apr 8 6:47 PMCharles Nolan ParkerChief Financial Officer
Grant/Award
104,544$1.60104,544(D)

View →

Dec 12, 2025Apr 8 6:47 PMCharles Nolan ParkerChief Financial Officer
Grant/Award
61,571$2.3361,571(D)

View →

Oct 12, 2025Apr 8 6:47 PMCharles Nolan ParkerChief Financial Officer
Grant/Award
32,406$3.0132,406(D)

View →

Mar 8, 2026Mar 10 11:22 PMTrafford ClarkeDirector
Grant/Award
33,435$1.6033,435(D)

View →

Mar 8, 2026Mar 10 11:21 PMWerner CautreelsDirector
Grant/Award
31,258$1.6031,258(D)

View →

Mar 8, 2026Mar 10 11:20 PMJohn Harold LeamanDirector
Grant/Award
33,435$1.6033,435(D)

View →

Mar 8, 2026Mar 10 11:19 PMIain D. DukesDirector, Chief Executive Officer
Grant/Award
231,336$1.60231,336(D)

View →

Mar 8, 2026Mar 10 11:18 PMCharles David PauzaChief Science Officer Virology
Grant/Award
118,367$1.60118,367(D)

View →

Mar 8, 2026Mar 10 11:17 PMNikolay SavchukDirector, Chief Operating Officer
Grant/Award
96,899$1.6096,899(D)

View →

Mar 8, 2026Mar 10 11:16 PMJack E StoverDirector
Grant/Award
33,435$1.6033,435(D)

View →

Mar 8, 2026Mar 10 11:15 PMRobert RedfieldChief Medical Officer
Grant/Award
108,854$1.60108,854(D)

View →

Mar 8, 2026Mar 10 11:12 PMMary Teresa ShoemakerDirector
Grant/Award
33,435$1.6033,435(D)

View →